What is the level of liabilities of Inventiva this year?
Inventiva has a debt balance of 101.59 M EUR this year.
Inventiva Liabilities 2025
Inventiva Liabilities
101.59 M EUR
Ticker
IVA.PA
ISIN
FR0013233012
WKN
A2DLV9
In 2025, Inventiva's total liabilities amounted to 101.59 M EUR, a 44.05% difference from the 70.53 M EUR total liabilities in the previous year.
Inventiva Aktienanalyse
What does Inventiva do?
Inventiva SA is a biopharmaceutical company based in France that specializes in the development of novel therapies for various diseases. The company was founded in 2002 by Pierre Broqua and Frédéric Cren to develop innovative drugs based on research on the human genome. Inventiva's business model is to develop a pipeline of drug candidates and either sell them or bring them into partnerships with other companies. The company has built a broad portfolio of patents and license agreements that allow it to develop a variety of products. Inventiva's research and development focuses on three key areas: fibrosis, oncology, and autoimmune diseases. In these areas, the company has several product candidates in various stages of clinical development. Inventiva's products include Lanifibranor, a drug for the treatment of fatty liver disease, which is currently in Phase III trials. Additionally, the company has several compounds in its oncology pipeline, including IVA337, IVA336, and IVA339, all of which have shown promising results in preclinical studies. In the field of autoimmune diseases, Inventiva is working on a compound called ABBV-157, which is being developed in collaboration with Abbvie. This compound is intended to help reduce inflammation in patients with rheumatoid arthritis and psoriasis. Overall, Inventiva has made significant progress in recent years and has achieved important milestones in the development of its products. The company has also entered into several partnerships with major pharmaceutical and biotech companies to bring its products to market. In 2020, Inventiva took the next important step in its growth strategy by announcing a merger with American company AbbVie. The acquisition is expected to accelerate the development and commercialization of Inventiva's products and provide the company with a strong partner in the international market. However, Inventiva has not limited itself to drug development. The company has also developed a range of services to support other companies in the development of new drugs. These include laboratory services, protein purification and analysis, cell culture, and more, offered through their own contract research organization (CRO) unit. In summary, Inventiva is an emerging company with a strong portfolio of products and services. The company has done excellent work in developing new medical technologies in recent years and is likely to have even more success in the future with the acquisition by AbbVie. Inventiva ist eines der beliebtesten Unternehmen auf Eulerpool.com.Liabilities Details
Assessing Inventiva's Liabilities
Inventiva's liabilities constitute the company's financial obligations and debts owed to external parties and stakeholders. They are categorized into current liabilities, due within a year, and long-term liabilities, which are due over a longer period. A detailed assessment of these liabilities is crucial for evaluating Inventiva's financial stability, operational efficiency, and long-term viability.
Year-to-Year Comparison
By comparing Inventiva's liabilities year-over-year, investors can identify trends, shifts, and anomalies in the company’s financial positioning. A decrease in total liabilities often signals financial strengthening, while an increase might indicate enhanced investments, acquisitions, or potential financial strain.
Impact on Investments
Inventiva's total liabilities play a significant role in determining the company's leverage and risk profile. Investors and analysts examine this aspect meticulously to ascertain the firm’s ability to meet its financial obligations, which influences investment attractiveness and credit ratings.
Interpreting Liability Fluctuations
Shifts in Inventiva’s liability structure indicate changes in its financial management and strategy. A reduction in liabilities reflects efficient financial management or debt payoffs, while an increase may suggest expansion, acquisition activities, or accruing operational expenses, each carrying distinct implications for investors.
Frequently Asked Questions about Inventiva stock
What were the liabilities of Inventiva compared to the previous year?
The liabilities of Inventiva have increased by 44.05% increased compared to the previous year.
What are the consequences of high debt for investors of Inventiva?
High liabilities can pose a risk for investors of Inventiva, as they can weaken the company's financial position and impair its ability to meet its obligations.
What consequences do low liabilities have for investors in Inventiva?
Low liabilities mean that Inventiva has a strong financial position and is able to meet its obligations without overburdening its finances.
How does an increase in liabilities of Inventiva affect the company?
An increase in liabilities of Inventiva can lead to the company having more obligations and potentially find it more difficult to meet its financial commitments.
How does a reduction in the liabilities of Inventiva affect the company?
A decrease in the liabilities of Inventiva can lead to the company having fewer obligations and a stronger financial position, which can make it easier for the company to fulfill its financial commitments.
What are some factors that influence the liabilities of Inventiva?
Some factors that can influence the liabilities of Inventiva include investments, acquisitions, operating costs, and sales development.
Why is the level of liabilities of Inventiva so important for investors?
The liabilities of Inventiva are important for investors as they serve as an indicator of the company's financial stability and provide investors with information on how the company meets its financial obligations.
What strategic measures can Inventiva take to modify the liabilities?
To change its liabilities, Inventiva can take measures such as cost savings, increasing revenue, selling assets, raising investments, or forming partnerships. It is important for the company to conduct a thorough review of its financial situation to choose the best strategic actions.
How much dividend does Inventiva pay?
Over the past 12 months, Inventiva paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Inventiva is expected to pay a dividend of 0 EUR.
What is the dividend yield of Inventiva?
The current dividend yield of Inventiva is .
When does Inventiva pay dividends?
Inventiva pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of Inventiva?
Inventiva paid dividends every year for the past 0 years.
What is the dividend of Inventiva?
For the upcoming 12 months, dividends amounting to 0 EUR are expected. This corresponds to a dividend yield of 0 %.
In which sector is Inventiva located?
Inventiva is assigned to the 'Health' sector.
Wann musste ich die Aktien von Inventiva kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Inventiva from 2/14/2025 amounting to 0 EUR, you needed to have the stock in your portfolio before the ex-date on 2/14/2025.
When did Inventiva pay the last dividend?
The last dividend was paid out on 2/14/2025.
What was the dividend of Inventiva in the year 2024?
In the year 2024, Inventiva distributed 0 EUR as dividends.
In which currency does Inventiva pay out the dividend?
The dividends of Inventiva are distributed in EUR.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
Andere Kennzahlen von Inventiva
Our stock analysis for Inventiva Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Inventiva Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
